MeSH tree: D12.776.872
Researchers at the University of Oulu have identified alpha-1 antitrypsin as a potential target for preventing spontaneous preterm birth. In a large genetic study of more than 200,000 mothers, a variant in the SERPINA1 gene, ...
Sep 3, 2026
0
5
When red blood cells break down, they release heme, a component of hemoglobin that can contribute to inflammation and damage tissues and blood vessels. Researchers at Lund University have identified a mechanism by which heme ...
Aug 31, 2026
0
2
A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with a remarkable ability to reverse new-onset type 1 diabetes (T1D) in a mouse model of the disease. ...
Jun 7, 2026
0
31
Researchers from the Paris Brain Institute and Sainte-Justine University Hospital in Montreal have, for the first time, revealed the key stages of vascular development in the brain, from birth through adulthood. Using a 3D ...
Apr 15, 2026
0
6
The investigational drug tonlamarsen—which is designed to lower blood pressure by reducing the production of angiotensinogen, a protein that turns into the hormone that regulates blood pressure—caused a significant and sustained ...
Mar 31, 2026
0
4
A naturally occurring protein in the human body could protect people from one of the world's biggest killers—sepsis. The protein's ability to reduce inflammation in a preclinical study raises hopes that it could be the first ...
Mar 3, 2026
0
8
A new study led by researchers at Moffitt Cancer Center found that blood-based DNA markers known as protein epiScores can help predict which colorectal cancer patients face a higher risk of cancer recurrence or death. Results ...
Feb 9, 2026
0
8
A randomized controlled study found that time-restricted feeding—a form of intermittent fasting—significantly reduced symptomatic disease activity and systematic inflammation in adults with Crohn's disease and overweight ...
Feb 9, 2026
0
87
Among individuals with cardiovascular disease or high cardiovascular risk and uncontrolled hypertension on multiple anti-hypertensive agents, a single subcutaneous dose of zilebesiran 300 mg led to a 5-mmHg reduction in systolic ...
Sep 1, 2025
0
13
Results from a clinical trial led by researchers from Queen Mary University of London, published today in JAMA, show that giving people with high blood pressure an injection every six months can lead to a meaningful, sustained ...
May 28, 2025
0
35
